EnzEng 2 EnzymeKinetics C V VII
EnzEng 2 EnzymeKinetics C V VII
EnzEng 2 EnzymeKinetics C V VII
V
Kelompok Bioproses Kelas C :
1. Gapenda Sari Kaban (13-066)
2. Evan Kurniawan (13-067)
3. Vivian (13-073)
4. Yudi Faradey P (13-081)
5. Alexander (13-089)
6. Andre Prasetia W (13-090)
7. Trecy Kartika (13-093)
8. Maria Paula S (13-094)
ENZYME ASSAY
The analysis for enzyme activity.
The results obtained from enzyme assays are not in weight of enzyme, but units of
catalytic activity.
One unit of enzyme activity
= the amount of enzyme which will catalyze the formation of 1 mol
product per minute under specified conditions
Enzyme assays must be carried out under conditions that are optimal for activity,
with the pH, temperature and concentration of reagents used in a predetermined
manner.
Enzyme assays must be made under initial velocity conditions.
The assay should always be tested to show that the velocity v is proportional to the
amount of enzyme added.
[Example] For the determination of the enzymatic activity of alcohol oxidase (AO)
from yeast, the following coupled reactions are utilized:
Methanol O 2
AO formaldehyde H 2 O 2
H 2 O 2 DH 2 HP 2H 2 O D
where DH2 is a dye precursor, D is the dye, and HP is the enzyme horseradish
peroxidase. The dye is monitored by means of a spectrophotometer at a wavelength
of 405 nm. The standard curve of the absorbance versus concentration of H2O2 was
found to be:
A405 0.0377C H 2 O 2 0.0123 (where C H 2 O 2 in mol/L)
A sample of clarified yeast cell lysate assayed for AO activity by this method gave a
rate of change of A405 of 0.082/min after a dilution of 1:40,000. Calculate the AO
concentration in units per mL, where 1 unit (U) is equal to the amount of enzyme
producing 1 mol of H2O2 per minute under the conditions of the assay.
Solution:
A405 0.0377C H 2 O 2 0.0123 or A405 0.0377C H 2O 2
C H 2 O 2
t
A405 / 0.0377
0.082 min -1
mol
U
2.175
2.175
L
t
L - min
L
0.0377
mol
MICHAELIS-MENTEN KINETICS
k1
E+S
k-1
ES
k2
E+P
A. Rapid-Equilibrium Approach
[E] and [ES] are in equilibrium (it implies that k2 << k1).
[E] [S] k 1
k [ E ][S]
d [ P]
d [S]
k 2 [ ES] 2
dt
dt
Km
[ES]
[E]t
K
1 m
[S]
v k 2 [ ES]
Km
K
Km
K m [S] K m [S]
1
[S]
k1
k-1
k2
ES
E+P
d [ ES]
k1 [ E ][S] ( k 1 k 2 )[ ES] 0
dt
k k2
v k 2 [ ES]
[E]
k 1 k 2
[ ES]
k1 [S]
[ES]
[E] t
k 1 k 2
1
k1 [S]
k 2 [ E]t [S]
V [S]
max
k 1 k 2
[S] K m [S]
k1
k 1 k 2
k1
1
(Note: K m k in the equilibrium approach.)
1
k1
k-1
ES
k2
E+P
Vmax [S]
K m [S]
d [S] d [ P]
dt
dt
* Note: keep [S] < 0.05[S]0 when determining the reaction rate.
A. Lineweaver-Burk Plot:
K
1
1
1
m
x-axis intercept:
0
Km 1
1
B. Hanes-Woolf Plot
K
[S]
1
[S] m
v
Vmax
Vmax
1
1
[S]
Km
C. Eadie-Hofstee Plot
vKm + v[S] = Vmax[S]
v[S] = Vmax[S] vKm
or v Vmax K m
v
[S]
1
1
v.s.
v
[S]
(Lineweaver-Burk plot)
1
v
[S]
v
v
[S]
[Example] The following data has been obtained for two different initial enzyme
concentrations for an enzyme-catalyzed reaction.
v at [E]t = 0.015 g/L
(g/L-min)
1.14
0.87
0.70
0.59
0.50
0.44
0.39
0.35
[S]
(g/L)
20.0
10.0
6.7
5.0
4.0
3.3
2.9
2.5
[S] m
v
Vmax
Vmax
(Hanes-Woolf plot)
Vmax
1.67
g
111
[ E ] t 0.015
g enzyme - min
Vmax
1.0
g
114
[ E ]t 0.00875
g enzyme - min
[ S]
[ s ]0
Vmax dt
dt
K m [S]
K m [S]
[S]
d [S] Vmax t K m ln 0 ([S]0 [S])
[S]
[S]
K m [S]0
[S]0 [S]
ln
Vmax
t
[S]
t
1
[S]
[S]
1 [S]0 [S]
t
0
max
or t ln [S] K K
m
m
[S]0 [S]
.
t
Note: (1) Reaction may be product inhibition. (2) Reaction conditions may change.
(pH change) (3) Reaction may approach an equilibrium position. (S P)
Michaelis-Menten assumptions and reaction scheme are invalid.
[Example] An enzyme reaction follows the Michaelis-Menten kinetic, with Km =
0.03 mol/L and Vmax = 13 mol L1 min1. An incoming substrate has a concentration
of 10 mol/L and a flow rate of 10 L/h. (a) What should be the size of a steady-state
continuous stirred-tank reactor for a 95% conversion? Assume that the enzyme
concentration in the reactor is constant. (b) What should be the size of the reactor if
you employ a plug-flow reactor?
Solution:
(a) Continuous stirred-tank reactor
Material balance on the substrate:
{Rate of input} {Rate of output} = {rate of disappearance}
F [S]0 F [S]
Vmax [S]
Vreactor
K m [S]
10 (10 0.5)
Vreactor = 0.13 L
dt
K m [S]
max
[ S]
dt
13 0.03 ln
[ s ]0
K m [S]
[S]
d [S] Vmax K m ln 0 ([S]0 [S])
[S]
[S]
10
(10 0.5)
0.5
= 0.74 min
L
h
60 min
ENZYME INHIBITION
Enzyme inhibitions may be irreversible or reversible.
* Irreversible inhibitors (such as heavy metals) form a stable complex with
enzyme and reduce enzyme activity.
May be reversed only by using chelating agents (such as EDTA and citrate).
* Reversible enzyme inhibitions: competitive, noncompetitive, and uncompetitive.
Competitive Inhibition
k1
E+S
ES
k-1
k2
E+P
+
I
KI
EI
Km
k 1 [E] [S]
[E] [I]
; KI
k1
[ES]
[EI]
K
[E] [S]m [ ES]
[EI]
K
K [I]
d [ P]
k 2 [ ES]
dt
or
[I]
K [I]
[ E] m
[ ES]
KI
[S] K I
[ES]
K m
[E] t [ S ]
[I ]
[S]
1
K I
k 2 [ E]t [S]
Vmax [S]
[I]
[I]
[S] K m 1
[S] where Vmax = k2[E]t
K m 1
KI
KI
Acid phosphatases are produced by erythrocytes, the liver, kidney, spleen, and
prostate gland (). From the clinical standpoint, the enzyme from the
prostate gland is most important because an increased concentration in the blood is
frequently an indication of cancer of the prostate gland. The phosphatase from the
prostate gland is strongly inhibited by the tartrate ion, while acid phosphatases
from other tissues are not. How can this information be used to develop a specific
procedure for measuring the activity of the acid phosphatase of the prostate gland
in human blood serum?
Answer: Measure the total acid phosphatase activity in the presence and absence of
tartrate ion.
Part of the medical treatment for methanol poisoning is to give the patient ethanol
(ethyl alcohol), either by mouth or intravenously (), in amounts that would
cause intoxication in a normal individual. Explain why this treatment is effective.
Answer: Ethanol competes with methanol for the active site of alcohol
dehydrogenase.
Noncompetitive Inhibition
Km
E+S
k2
ES
I
KI
E+P
KI
Km
EI + S
Km
EIS
k1
[ES]
[ESI]
KI
[EI]
[ESI]
K
[E] [S]m [ ES] ;
[EI]
K [I]
[I]
[I]
[ E] m
[ ES] ; [ESI]
[ ES]
KI
[S] K I
KI
Km
K [I] [I]
1 m
[S] K I K I
[S]
or [ES]
[E]t [ S ]
[I]
[I]
[S] 1
K m 1
KI
K I
d [ P]
v
k 2 [ ES]
dt
Vmax
[S]
[I]
1
K I
k 2 [ E]t [S]
K m [S]
[I]
[I]
[S] 1
K m 1
KI
KI
Vmax
[I]
K I
Uncompetitive Inhibition
Km
E+S
k2
ES
E+P
+
I
KI
ESI
Km
[E]
K
[I]
k 1 [E] [S]
[ES] [I]
; KI
k1
[ES]
[ESI]
Km
[I]
[ ES] and [ESI]
[ ES]
[S]
KI
or [ES]
k 2 [ E]t
k 2 [ E]t [S]
d [ P]
k 2 [ ES]
dt
Km
[I]
[ I]
K m [S] 1
K I
K I
[S]
Vmax
[I]
K I
[E]t
Km
[I]
1
K I
[S]
Vmax
[S]
[ I]
1
Km
[S] K m , app [S]
[I]
1
K I
Km
and K m , app
[I]
K I
m
Lineweaver-Burk equation: v V [S] V
max
max
Plot
1
1
versus
.
v
[S]
y-axis intercept
1
Vmax
; x-axis intercept
1
Km
VI
Kelompok Bioproses C;
1. Khairull Fahmi
2. Mhd.Reza Rahmadhan
3. Ariel Seumupa
4. Devi Sahara
5. Afdal Supi
6. M. Zulfadli
7. Christina Eka
8. Florentina Pandiangan
[S] = 0.02 M
1/v
[I]
0.68
0
1.02
0.0012
1.50
0.0022
1.83
0.0032
2.04
0.0037
2.72
0.0044
3.46
0.0059
where v = mol/L-min and [I] is inhibitor molar concentration. Determine the kinetic
parameters (Km and KI).
Solution:
K
1
1
1
m
(Lineweaver-Burk plot)
v Vmax [S] Vmax
Remarks:
Vmax
5 0 .2
[S]
[I]
0.0012
1
1
KI = 6.0 103 M.
KI
K
I
3
2
K m [S]
7.77 10 0.2
Vmax , app
Vmax
[I]
max
1
or V
KI
max , app
[I]
1
K I
max
versus [I]; slope
.
Plot V
KI
max , app
[I]
0
0.0012
0.0044
0.0060
Vmax,app
5
4
2
1.33
Vmax
1
1.25
2.5
3.76
Vmax,app
4.0
3.5
3.0
2.5
Vmax
Vmax,app 2.0
1.5
1.0
0.5
0
[I] 103, M
Slope
1
0.45
KI
or KI = 2.2 103 M
#
[S] (mmol L )
1.25
1.67
2.50
5.00
10.0
(a) What kind of inhibition is involved? (b) Determine Vmax and Km in the absence
and presence of inhibitor.
Solution:
Eadie-Hofstee plot:
v Vmax K m
Plot v versus
v
[S ]
v
[S]
4.5
4.0
v, mmol/L-min
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
0.2
0.4
0.6
0.8
v/[S], min
1.0
1.2
1.4
1.6
() In the absence of inhibitor, Km = 2.5 mmol L1, Vmax = 5.0 mmol L1 min1.
() With inhibitor, Km, app = 2.5 mmol L1, Vmax, app = 3.0 mmol L1 min1.
It is of noncompetitive inhibition.
#
glucose isomerase
k1
k-1
ES
fructose
k2
E+P
k-2
By steady-state approximation,
d [ ES]
k1 [S][ E ] ( k 1 k 2 )[ ES] k 2 [ E ][ P] 0
dt
1
2
or [ E] k [S] k [ P] [ ES]
1
2
k 1 k 2
[ E ]t [ ES] [ E ] [ ES] 1
k1[S] k 2 [ P]
k [ P] ( k 1 k 2 )
d [S] d [ P]
k 2 [ ES] k 2 [ E][ P] k 2 2
[ ES]
dt
dt
k1 [S] k 2 [ P]
k 2 [ P] ( k 1 k 2 )
[ E]t
k1 [S] k 2 [ P]
k k [S] k 2 k 2 [ P] k 2 [ P] (k 1 k 2 )[ E]t
1 2
k 1 k 2
k1 [S] k 2 [ P] k 1 k 2
1
k1 [S] k 2 [ P]
k2
k1k 2 [S] k 1k 2 [ P]
[ E]t
k 1 k 2
k 1 k 2
k1 [S]
k [ P]
2
1
k 1 k 2 k 1 k 2
Set
k 1 k 2
k k2
K S ; 1
K P ; k 2 [ E ]t VS ; k 1 [ E] t VP
k1
k 2
VS
V
[S] P [ P]
K
K
v S [S] [PP]
1
KS KP
E + nS
[E] [S]n
Km
[ES n ]
[E]
k-1
ESn
Vmax [S]n
v
vK m v[S]n Vmax [S]n
K m [S]n
vK m (Vmax v )[S]n
ln K m ln
ln
(Vmax v ) n
[S]
v
(Vmax v )
n ln[S]
v
v
(Vmax v )
Km
1 [ES n ]
n
[S]
n
Km
K
[S]
K m [S]n
m
1
[S]n
Km
E + nP
Km
[ES n ] [ E]t [E] [ES n ]
n
[S]
v k 2 [ ES n ]
k2
n ln[S] ln K m
SUBSTRATE INHIBITION
The enzyme, which is probably oligomeric, has multiple binding sites for substrate.
Km
E+S
k2
ES
+
S
E+P
KSI
ES2
[E] [S]
[ES] [S]
; K SI
[ES]
[ES 2 ]
or [ES]
K
[S]
[E]t
Km
[S]
1
K SI
[S]
k 2 [ E]t
Vmax [S]
d [ P]
k 2 [ ES]
dt
[S]2
Km
[S]
K m [S]
1
K SI
K SI
[S]
Remarks:
(1) At low [S], the term involving [S]2 can be neglected, and inhibition effect is not
observed.
v
Vmax [S]
[S]2
K m [S]
K SI
[S]
max
v K [S]
m
Vmax [S]
V
max
2
[S]
[S]
1
[S]
K SI
K SI
(3) The substrate concentration resulting in the maximum reaction rate, [S]max, can be
determined by setting dv/d[S] = 0.
dv
d
d [S] d [S]
Km
Vmax [S]
[S]2
[S]
K SI
[S]max
K m K SI
KA
[EB]
; KB
[EA]
[EAB]
[EB]
[EAB]
KA
K
K
K K
[EAB] ; [EA] B [EAB] ; [E] A [EA] A B [EAB]
[A]
[B]
[A]
[A] [B]
K AK B K B K A
1 [EAB]
[A] [B] [B] [A]
k 5 [E]t
Vmax [A] [B]
d [ P]
k5 [ EAB]
K AKB KB K A
dt
1 K AK B K B [ A ] K A [ B] [ A ][ B]
[A] [B] [B] [A]
E + AX
EX + B
k1
k2
EAX
k-1
k3
k4
EBX
k-3
d [ EBX ]
k 3 [EX] [B] ( k 3 k 4 ) [EBX] 0
dt
d [ EAX ]
k1 [E] [AX] ( k 1 k 2 ) [EAX] 0
dt
[E]
E + BX
[EX]
[EAX]
k 2 [EAX] k 4 [EBX]
EX + A
k 3 k 4
[ EBX ]
k 3 [B]
k4
[EBX]
k2
( k 1 k 2 )
( k k 2 )k 4
[ EAX ] 1
[ EBX ]
k1 [AX]
k1k 2 [AX]
( k 1 k2 )k4 k4 k 3 k4
1 [EBX]
k2
k3[B]
k1k2 [AX]
v k 4 [EBX]
k 4 [E]t
Vmax
( k 1 k 2 )k 4 k 4 k 3 k 4
K
K
1 Km A B
[ AX ] [ B]
k1k 2 [AX] k 2
k 3 [B]
where Vmax k 4 [ E ]t ; K m 1
k4
( k k 2 )k 4
k k4
; K A 1
; K B 3
k2
k1k 2
k3
ln k ln A
E
RT
Plot ln v versus
1
E
, slope
T
R
kT 2
E 1
1
kT 1
R T2 T1
Km
K2
EH + S
+
H+
Km
EHS
k2
EH + P
[EH] [S]
[EH] [H ]
[E - ] [H ]
; K1
;
K
2
[EHS]
[EH 2 ]
[EH]
K1
EH2+
Vmax [S]
K
[H ]
[S]
K m 1 2
[H ] K1
or v
Vmax [S]
K
[H ]
where K m ,app K m 1 2
K m , app [S]
K 1
[H ]
SH + E
Km
ESH
k2
K1
E + HP
Km
[SH ] [E]
[S] [H ]
;
K
1
[ESH ]
[SH ]
v k 2 [ESH ]
Vmax [S]
K
K m 1 1 [S]
[H ]
VII
Kelompok bioprocess kelas C :
1. Gewa Handika (13-082)
2. Sy. Nadiratuzzahrah (13-083)
3. Yayang Afandy (13-084)
4. Muhammad Ridha (13-085)
5. Finnya Angkie Winoto (13-087)
6. Irsa Septiawan (13-100)
7. M. Faizul Hisham (13-103)
8. Salwa Jody Gustia (13-104)
HA
Ka
[H ][A - ]
[HA]
or
[H ] K a
[HA]
[A - ]
If the concentrations of the buffer components are higher than added acid
(or base), the buffer ratio (and so the pH) will change little.
* The nature of the buffer may play an important role in enzyme stabilization.
It is commonly observed that carboxylic and sulfonic acid buffers stabilize
enzymes.
Tris buffer has been known to cause a significant number of problems.
* Ionic strength may have a strong effect on enzyme stability and activity.
urease
HCO3- + 2NH4+
ENZYME DEACTIVATION
Protein structure is stabilized by weak forces.
Forces that maintaining protein structure: hydrogen bonding, ionic attractions,
hydrophobic interactions, and S-S linkages.
Native protein structure is only marginally stable.
Stages of protein unfolding:
N = native conformation
A* = critically activated state
ID = incompletely disordered conformation
RC = random coil (fully denatured state)
There are many factors that can cause reduction in enzyme activity.
It is not the individual factors but their combinations that determine rates of
enzyme deactivation.
The protein denaturants can be classified into physical, chemical, and
biological denaturants.
(1) Physical denaturant
Heat
Target: hydrogen bonds
Driving force: increase of denatured conformations due to increased
thermal movement and decreased solvent structure; irreversible
covalent modification (e.g., disulfide interchange)
End product: highly disordered conformation; aggregates
Cold
Target: hydrophobic bonds; solvated groups
Driving force: altered solvent structure; dehydration
End product: aggregates; inactive monomers
Mechanical forces
Target: solvated groups; void volume
Driving force: changes in solvation and void volume; shearing
End product: highly disordered conformation; inactive monomers
Radiation
Target: functional groups (e.g., cySH, peptide bonds)
Driving force: decrease of structure-forming interactions after photooxidation or attack by radicals
End product: highly disordered conformation; aggregates
(2) Chemical denaturant
Acids
Target: buried uncharged groups (e.g., his, peptide bonds)
Driving force: decrease of structure-forming ionic interactions
End product: random coil
Alkali
Target: buried uncharged groups [e.g., tyr, cySH, (cyS)2]
Driving force: decrease of structure-forming ionic interactions
End product: random coil
Organic H-bond-formers
Target: hydrogen bonds
Driving force: decrease of structure-forming H bonds between water
and native conformation
End product: random coil
Salts
Target: polar and nonpolar groups
Driving force: salting in/salting out bias of polar and nonpolar groups
in solvent
End product: highly disordered conformation
Solvents
Target: nonpolar groups
Driving force: solvation of nonpolar groups
End product: highly disordered conformation; peptide-chains with
large helical regions
Surfactants
Target: hydrophobic domains (all surfactants) and charged groups
(ionic surfactants only)
Driving force: formation of partially unfolded structures including
micelle-like regions
End product: incompletely disordered conformation; large helical
regions
Oxidants
Target: functional groups (e.g., cySH, met, try, and others)
Driving force: decrease of structure-forming and/or functional
interactions
End product: inactivated enzyme; sometimes disordered structure
Heavy metals
Target: functional groups (e.g., cySH, his, and others)
Driving force: masking of groups pertinent to structure or function
End product: inactivated enzyme
Chelating agents
Target: cations important for structure or function
Driving force: ligand substitution or cation removal
End product: inactivated enzyme
(3) Biological denaturant
Proteases
Target: peptide bonds
Driving force: hydrolysis of peptide bonds
End product: oligopeptides, amino acids
kd
ED
Decay of enzyme activity with time does not always follow the first-order model.
* The profile of luciferase deactivation contains two different linear regions.
A model that fits the data of
luciferase deactivation is:
ED1
kd1
kr
EN
kd2
ED2
d [E N ]
(k d 1 k d 2 )[E N ] k r [E D1 ]
dt
d [E D1 ]
k d 1 [E N ] k r [E D1 ]
dt
EN + ED1
ED1
Km
kd1
ED2
ENED1
kd2
EN + hydrolysis products
d [E N ]
k d [ E N ][ poison]
dt
k1
k-1
ENS
k2
EN + P
kd
ED
K m [ E N S]
Km
[ E N S]
k1
[S]
[S]
[ E N ]t [ E N ] [ E N S] [ E N ]
[ E N ] [ E N ] 1
Km
K m
[E N ]
[ E N ]t
[S]
1
Km
d [ E N ]t
k [E ]
d ln[E N ]t
kd
k K
k d [ E N ] d N t
d m
[S]
[S] or
dt
dt
K m [S]
1
1
Km
Km
glucose.
Organic solvents
There are many cases that addition of organic solvents cause
denaturation at high concentrations but afford considerable
stabilization at low concentrations.
A possible rationale: prevention of hydrogen bond rupture.
Salts
Cations such as Ca, Cu, Fe, Mn, Mo, and Zn have an effect on the
stability and activity of metalloenzymes.
* Calcium helps to stabilize the tertiary structure of -amylase of
Bacillus caldolyticus.
Ca2+ can serve as a stabilizing bridge analogous to a disulfide
bond.
Polymer additives
Natural or synthetic polymers such as gelatin, albumin, or
polyethylene glycols can increase the heat stability of enzymes.
(2) Chemical modification of enzymes
Crosslinking with bifunctional reagents such as glutaraldehyde
To limit access by proteases and may also serve to lock the protein
into an active configuration.
Adding polyamino acid side chains to the R-groups of certain amino acid
residues
Use acylation or alkylation to introduce other substituents.
(3) Immobilization of enzymes
Immobilized enzymes are often more stable than enzymes in solution
Examples of enzyme stabilization:
* Glucoamylase
Methods: addition of substrate analogs, glucose, gluconolactone
Effect: enhanced thermal stability
* Lactate dehydrogenase
Methods: addition of substrate lactate or effector fructose-diphosphate
Effect: greater thermal stability
Note: the enzyme is destabilized by addition of pyruvate substrate.
* -Amylase
Method: addition of 5070% sorbitol
Effect: better storage and thermal stability
* -Amylase (Bacillus caldolyticus)
Method: addition of Ca2+
Effect: greatly enhanced thermal stability
* Chymotrypsin
Method: addition of 5090% glycerol
Effect: improved resistance to proteolysis
* -Galactosidase
Methods: addition of 510% ethanol or 2-propanol
Effect: increased heat stability
Note: similar levels of methanol, n-propanol destabilize the enzyme.
* Trypsin
Method: addition of polyalanyl (~10 units long) to proteins amino groups
Effect: more proteolysis, heat deactivation resistance
* Asparaginase
Methods: succinyl substituents added using the acid anhydride
Effect: increased protease resistance
* Glycogen phosphorylase
Methods: butyl or propyl substituents added using the aldehyde and NaBH4
Effect: enhanced thermal stability
* Papain
Method: cross-linked using glutaraldehyde
Effect: better thermal stability
Comments on methods for enzyme stabilization:
(1) The influence of a particular chemical or strategy on one enzymes stability
cannot always be extrapolated to other enzymes.
(2) The stabilizing effect depends often on a particular combination of solution
composition and temperature.